Specify a stock or a cryptocurrency in the search bar to get a summary
Onconetix Inc
ONCOOnconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio. Address: 201 East Fifth Street, Cincinnati, OH, United States, 45202
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ONCO
Dividend Analytics ONCO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ONCO
Stock Valuation ONCO
Financials ONCO
Results | 2019 | Dynamics |